Most ALPS patients are affected by heterozygous germline mutations in the Fas cell surface death receptor gene (FAS) via autosomal dominant inheritance (Jackson et al., 1999; Holzelova et al., 2004; Oliveira et al., 2010). This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.